Company intelligence / Profile preview

Vilas Ventures

Boca Raton, Florida, United States

Ownership: Private
Development stage: Other

Overview

Vilas Ventures invests in high-growth, founder-led healthcare companies, focusing on technology-backed solutions such as diagnostics, SaaS, and tech-enabled services. Notably, it led a $13.5M Series A3 round for CND Life Sciences, a neurodegenerative diagnostics company that commercialized the skin-based Syn-One Test® for Parkinson’s disease and related synucleinopathies.

Industry: Investors

Partnerships

CND Life SciencesCortechs.aiRoshal HealthJSCM Group

Beyond the preview

Go deeper on Vilas Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vilas Ventures.

Explore the full profile